175 results on '"Quintarelli C"'
Search Results
2. T2EVOLVE: STANDARDIZATION OF PRE-CLINICAL AND CLINICAL DEVELOPMENT OF ENGINEERED T CELL THERAPY IN EUROPE; A CROSS FUNCTIONAL MULTI STAKEHOLDER INITIATIVE
3. CD28.OX40 co-stimulatory combination is high associated activity with of CAR.CD30 long in vivoT persistence cells and
4. Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
5. Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia
6. 443 T-cell repertoire in metastatic melanoma patients developing skin leukoderma after treatment with checkpoint inhibitors
7. Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance
8. Relation between Lupus Anticoagulant and Splanchnic Venous Thrombosis in Cirrhosis of the Liver.
9. ADOPTIVE CELL IMMUNOTHERAPY IN MEDULLOBLASTOMA BASED ON T CELLS REDIRECTED TOWARD TUMOR CELLS BY PRAME SPECIFIC alpha beta TCR GENE MODIFICATION
10. MOLECULAR EVALUATION OF ZNF224 MRNA EXPRESSION IN CML PATIENTS AS A NOVEL DETERMINANT OF TKI RESPONSIVENESS
11. Advanced-stage Hodgkin Lymphoma: US/Chest Radiography for Detection of Relapse in Patients in First Complete Remission - A Randomized Trial of Routine Surveillance Imaging Procedures
12. Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase CML cells
13. Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase
14. Le fosfatasi SHP1 e SHP2 nella resistenza in vitro all’STI
15. A novel AF4/MLL hybrid gene lacking the AF4 transactivating domain in acute lymphoblastic leucemia
16. Thyrosine phosphatase as modulators of in vitro resistance to STI571
17. A novel MLL/AF4 fusion gene lacking the AF4 transactivating domain in infant acute lymphoblastic leucemia
18. P230 CML has a 2% incidence in Italian population
19. Association between high values of D-dimer and Tissue-plasminogen activator activity and first gastrointestinal bleeding in cirrhotic patients
20. LIPOPROTEIN (A) AND FIBRINOLYTIC SYSTEM IN LIVER-CIRRHOSIS
21. Lupus anticoagulant and increased thrombin generation in patients with systemic lupus erythematosus
22. Fibrinolytic balance and lupus anticoagulant in patients with repeated fetal loss
23. 1-Year Survey of Patients with Advanced Liver Cirrhosis: Prognostic Value of Clinical and Laboratory Indexes Identified by the Cox Regression Model.
24. Methods for detecting lupus anticoagulants and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus.
25. High plasma levels of von Willebrand factor as a marker of endothelial perturbation in cirrhosis: Relationship to endotoxemia.
26. Generation Of Virus-Specific Cytotoxic T Lymphocytes (CTLS) Resistant to the Immunosuppressive Drug Tacrolimus (FK506)
27. Polyclonal Prame-Specific Cytotoxic T Lymphocytes Generated Using Protein-Spanning Pools of Overlapping Pentadecapeptides Target Chronic Myeloid Leukemia
28. Genetic Modification of Antigen-Specific Cytotoxic T Lymphocytes (CTLS) Restores Their Ability to Respond to Interleukin-7 (IL-7)
29. Engineering CD19-Redirected T Lymphocytes to Enhance Their Safety and Efficacy
30. Preferentially Expressed Antigen of Melanoma (PRAME)-Specific Cytotoxic T-Lymphocytes (CTLs) and Transgenic T Cells To Target Chronic Myelogenous Leukemia (CML).
31. Gene Transfer of IL-7R alpha (IL-7Rα) on Antigen-Specific Cytotoxic T Cells (CTLs) Restores Their Ability To Respond to IL-7 Cytokine.
32. Transgenic Expression of IL15 Selectively Expands Antigen Specific Cytotoxic T Cells (CTLs) Enhancing Their Anti-Tumor Effect In Vivo.
33. EVALUATION OF D-DIMER IN PATIENTS WITH LIVER-CIRRHOSIS
34. LUPUS ANTICOAGULANT IN LIVER-CIRRHOSIS
35. Succesfull removal of antiphospholipid antibodies using repeated plasma-exchange and prednisone
36. Lupus anticoagulant and the fibrinolytic system in young patients with stroke.
37. PD‐1‐induced T cell exhaustion is controlled by a Drp1‐dependent mechanism
38. Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver.
39. Strategy to prevent epitope masking in CAR.CD19+ B-cell leukemia blasts
40. Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia
41. Multicentre harmonisation of a six-colour flow cytometry panel for naïve/memory T cell immunomonitoring
42. The immune system of children: the key to understanding SARS-CoV-2 susceptibility?
43. Universal Ready-to-Use Immunotherapeutic Approach for the Treatment of Cancer: Expanded and Activated Polyclonal γδ Memory T Cells
44. Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma
45. Role of interferon-γ in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation
46. Human CAR NK cells: A new non-viral method allowing high efficient transfection and strong tumor cell killing
47. 373 Decreases of tissue-plasminogen activator inhibitor (PAI) by defibrotide
48. Bevacizumab-mediated tumor vasculature remodelling improves tumor infiltration and antitumor efficacy of GD2-CAR T cells in a human neuroblastoma preclinical model
49. Adoptive immunotherapy using prame-specific t cells in medulloblastoma
50. MicroRNAs in neuroblastoma: Biomarkers with therapeutic potential
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.